Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
14.37%
↑ 110% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-143.35%
Historical baseline
PeriodValue
202514.37%
2024-104.89%
2023-177.79%
2022-100.71%
2021-491.11%
20200.00%